The cannabis industry makes strides once again, as cannabidiol (CBD) is listed for the first time ever in one of the country’s largest pharmaceutical drug directory.
The CBD products are hemp-derived supplements manufactured by HempMeds Real Scientific Hemp Oil (RSHO) Gold Label as well as Kannaway Pure Gold hemp-derived CBD; two subsidiaries under the Medical Marijuana Inc. company. That makes them the first two hemp-derived CBD products to be included in the Prescribers’ Digital Reference, also known as the PDR – Physicians’ Desk Reference.
“It’s an honor for our portfolio of companies to have the first CBD supplements listed in the iconic PDR, which has been a resource for healthcare providers for over 70 years,” commented Medical Marijuana Inc. CO Dr. Stuart Titus. “We hope that this will help healthcare providers understand more about the benefits of our high-quality CBD products.”
“Additionally, we are conducting a brief, exploratory and collaborative clinical study to explore this product as a health-promoting dietary supplement in prediabetic individuals. When complete, the study results will be incorporated in the product dossier and published in our label content within PDR to help healthcare providers become more familiar with the evidence-based wellness-supporting values of our hemp-derived dietary supplements,” Dr. Titus says.
“Here, one can find relevant information regarding the safety and potential effectiveness of many pharmaceutical preparations – as well as now information in regards to dietary supplements,” HempMeds president Tom Morrow disclosed to Benzinga.
“HempMeds and its hemp-derived CBD products have been the subject of much national and international dialogue, with clinical research in Brazil and Mexico in regards to epilepsy patients,” Morrow explained. “We are excited to be the first company to list a hemp-derive CBD product in the PDR, so that doctors, pharmacists and other health care providers can easily access information and become more educated on this topic. We look forward to adding to our initial listing as our continuing research concludes and patient data/experience becomes available.”
Why Is This Significant For The Cannabis Industry?
The PDR is a reference publication used by physicians as well as doctors, and even patients, to learn more about various pharmaceutical medications – and now, CBD, too. It’s a huge milestone for a CBD product to be listed in the publication for the first time ever, considering how widespread its use is.
The book is published each year, providing readers with a compilation of the same information typically found in drug inserts. It’s also published following FDA guidelines, including information on each medicine such as class, DEA class, description, common brand names, how it is applied (liquid or injection), dosage, indications, adverse reactions, drug interactions, and pharmacokinetics.
The HempMeds and Kannaway products are found in the “Dietary Supplement prepared from the industrial hemp oil” category in the book. They’re the first cannabis-derived products to ever make it to such a widely-used medical publication.
Cannabis was always included in the U.S. Pharmacopoeia, the precursor of the Physician’s Desk Reference. The first time that cannabis was mentioned in the book was the 3rd edition of the US Pharmacopoeia, which was in 1851. It wasn’t until sometime in the early forties that cannabis was no longer included due to the passing of the Marijuana Stamp Act in 1937. Prior to that, cannabis was included in the book as a medication for over 20 ailments.
In the mid 1930’s, a Federal Government-backed campaign was out to destroy cannabis in all forms. They made use of newspapers, radio, and magazines to tell the public about how evil cannabis, and that using it would cause people to commit crimes and rape, molest children, and even commit axe murders, among other ludicrous claims.
The campaign was effective to say the least; people stopped using cannabis for medical purposes. Cannabis was eventually removed from the US Pharmacopoeia, and its use was outlawed.
Now that CBD medications are listed in the PDR, more people will have a better understanding of how to use cannabis supplements correctly. Legalization is one thing, but spreading knowledge and the correct use the plant as medicine is another uphill battle. Far too many people still don’t know much about how to use CBD correctly, but this is one big step for us all.